Qube Research & Technologies LTD Biogen Inc. Transaction History

Qube Research & Technologies LTD

$93.8 Billion
Q2 2025

A detailed history of Qube Research & Technologies LTD transactions in Biogen Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 743,309 shares of BIIB stock, worth $95.8 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

743,309

Previous 1,226,709 39.41%

Holding current value

$95.8 Million

Previous $168 Million 44.39%

% of portfolio

0.1%

Previous 0.2%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$113.38 - $135.49 $54.8 Million - $65.5 Million	-483,400 Reduced 39.41%	743,309 $93.4 Million
Q1 2025 May 15, 2025	BUY	$133.43 - $153.27 $18.1 Million - $20.8 Million	135,867 Added 12.46%	1,226,709 $168 Million
Q4 2024 Feb 14, 2025	BUY	$146.47 - $191.55 $109 Million - $142 Million	741,497 Added 212.25%	1,090,842 $167 Million
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $63.4 Million - $79.4 Million	335,113 Added 2354.64%	349,345 $67.7 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $16.5 Million - $20.5 Million	-86,613 Reduced 85.89%	14,232 $3.3 Million
Q1 2024 May 14, 2024	BUY	$212.02 - $267.71 $21.4 Million - $27 Million	100,845 New	100,845 $21.7 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $10.6 Million - $12 Million	-42,041 Reduced 86.92%	6,328 $1.63 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $13.3 Million - $15.4 Million	48,369 New	48,369 $13.8 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $57.7 Million - $70.1 Million	228,626 New	228,626 $63.3 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $26.8 Million - $31.9 Million	-143,066 Reduced 88.34%	18,881 $3.85 Million
Q1 2022 May 09, 2022	BUY	$193.77 - $244.14 $28.5 Million - $35.9 Million	146,864 Added 973.71%	161,947 $34.1 Million
Q4 2021 Feb 01, 2022	SELL	$223.92 - $287.77 $9.88 Million - $12.7 Million	-44,123 Reduced 74.52%	15,083 $3.62 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $4.94 Million - $6.44 Million	-17,445 Reduced 22.76%	59,206 $16.8 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $19.9 Million - $31.8 Million	76,651 New	76,651 $26.5 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $6.84 Million - $8.01 Million	-28,151 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $1.9 Million - $2.86 Million	8,045 Added 40.01%	28,151 $6.89 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $8.02 Million - $9.26 Million	-30,278 Reduced 60.09%	20,106 $5.7 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $12.2 Million - $16.1 Million	47,076 Added 1423.1%	50,384 $13.5 Million
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $889,355 - $1.13 Million	3,308 New	3,308 $1.05 Million
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $2.21 Million - $2.48 Million	-10,176 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$219.29 - $241.72 $2.23 Million - $2.46 Million	10,176 New	10,176 $2.38 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $2.91 Million - $3.68 Million	-10,440 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $2.77 Million - $3.62 Million	9,429 Added 932.64%	10,440 $3.69 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $61,032 - $72,737	-237 Reduced 18.99%	1,011 $293,000
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $324,642 - $459,151	1,248 New	1,248 $341,000

Others Institutions Holding BIIB

# of Institutions

1,015

Shares Held

131M

Call Options Held

2.73M

Put Options Held

2.47M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $18.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Biogen Inc. Transaction History